Revolution Medicines, Inc. (RVMD) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
RVMD currently has 198M outstanding shares. with limited dilution risk as only 26.1M additional shares (13.2%) are authorized for issuance. The company has diluted shareholders by 18.99% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 06, 2026 |
10-Q filing | 198.1M shares outstanding |
200M | 26M |
| Nov 05, 2025 |
10-Q filing | 189.2M shares outstanding |
190M | 26M |
| Aug 06, 2025 |
10-Q filing | 188.6M shares outstanding |
190M | 26M |
| May 07, 2025 |
10-Q filing | 188.1M shares outstanding |
190M | 26M |
| Feb 26, 2025 |
10-K filing | 167.7M shares outstanding |
170M | 26M |
| Nov 06, 2024 |
10-Q filing | 166.8M shares outstanding |
170M | 26M |
| Aug 07, 2024 |
10-Q filing | 165.1M shares outstanding |
170M | 26M |
| May 08, 2024 |
10-Q filing | 164.7M shares outstanding |
160M | 26M |
| Feb 26, 2024 |
10-K filing | 164.7M shares outstanding |
160M | 26M |
| Nov 06, 2023 |
10-Q filing | 109.2M shares outstanding |
110M | 26M |
| Aug 08, 2023 |
10-Q filing | 106.9M shares outstanding |
110M | 26M |
| May 08, 2023 |
10-Q filing | 106.3M shares outstanding |
110M | 26M |
| Feb 27, 2023 |
10-K filing | 90.5M shares outstanding |
90M | 26M |
| Nov 07, 2022 |
10-Q filing | 84.7M shares outstanding |
85M | 26M |
| Aug 09, 2022 |
10-Q filing | 87.7M shares outstanding |
88M | 26M |
| May 09, 2022 |
10-Q filing | 74.2M shares outstanding |
74M | 26M |
| Feb 28, 2022 |
10-K filing | 74.2M shares outstanding |
74M | 26M |
| Nov 10, 2021 |
10-Q filing | 73.7M shares outstanding |
74M | 26M |
| Aug 11, 2021 |
10-Q filing | 73.6M shares outstanding |
74M | 26M |
| May 10, 2021 |
10-Q filing | 73.4M shares outstanding |
73M | 26M |
| Mar 02, 2021 |
10-K filing | 73.4M shares outstanding |
73M | 26M |
| Feb 03, 2021 |
S-1/A filing: The company is offering 5,000,000 shares of common stock at a price of $46.13 per share. |
66M | 26M |
| Feb 01, 2021 |
S-1 filing: The filing is an S-1 form for an offering of 4,000,000 shares of common stock with an option for underwriters to purchase an additional 600,000 shares. |
66M | 25M |
| Nov 12, 2020 |
10-Q filing | 66.4M shares outstanding |
66M | 20M |
| Aug 10, 2020 |
10-Q filing | 65.9M shares outstanding |
66M | 20M |
| Jul 06, 2020 |
S-1 filing: The company is offering 5,500,000 shares of its common stock, with underwriters having an option to purchase up to an additional 825,000 shares. |
65M | 20M |
| May 14, 2020 |
10-Q filing | 59.0M shares outstanding |
59M | 14M |
| Feb 11, 2020 |
S-1/A filing: This is the initial public offering of shares of common stock of Revolution Medicines, Inc. We are selling 14,000,000 shares of our common stock. The estimated initial public offering price is between $16.00 and $17.00 per share. |
N/A | 14M |
| Feb 03, 2020 |
S-1/A filing: This is an S-1/A filing for the initial public offering of common stock by Revolution Medicines, Inc. |
N/A | 12M |
| Jan 17, 2020 |
S-1 filing: This is an S-1 filing for Revolution Medicines, Inc. registering common stock with a proposed maximum aggregate offering price of $100,000,000. |
N/A | 0 |